EID Parry Q1 FY27 Results Analysis: PAT Plunges 42.5%, Policy Headwinds Persist (EIDPARRY)
EID Parry (India) Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 9,017.52 Cr (+3.42% YoY) and PAT growth of -32.93% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 12, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 9,017.52 Cr (+3.42% YoY) |
| PAT (Q1) | Rs. 311.50 Cr (-32.93% YoY) |
| EBITDA margin | 8.66% (-161 bps YoY) |
| EPS (Q1) | Rs. 7.96 (-42.50% YoY) |
| Market cap | Rs. 13,813.65 Cr |
| CMP | Rs. 772.50 |
Quarter Snapshot
Revenue grew just 3.4% YoY while PAT attributable to owners plunged 42.5%, reflecting severe margin compression and higher costs. Policy headwinds (sugar export ban, ethanol stagnation) and structural cost increases from recent acquisition weighed on profitability. The crop protection segment showed strong revenue growth from NACL consolidation, but underlying business challenges remain significant.
Key Investment Insights
Key Positives
- PSRIPL bank loans fully repaid by Jun 30, 2026, as planned
- PSRIPL SEZ exit on track for Sep 30, 2026
- Standalone sugar revenue grew 18.2% YoY to Rs.410 Cr
- Nutraceuticals EBIT loss narrowed from Rs.9.97 Cr to Rs.0.11 Cr, near breakeven
- CPG EBIT loss narrowed from Rs.17.47 Cr to Rs.11.98 Cr
- Crop protection revenue surged 72.5% YoY to Rs.1,250.76 Cr
Risk Factors
- PAT attributable to owners fell 42.5% YoY
- EBITDA margin contracted 161 bps to 8.66%
- Standalone loss after tax widened from Rs.27.92 Cr to Rs.89.29 Cr
- Distillery EBIT halved from Rs.20.27 Cr to Rs.8.66 Cr due to lower ENA offtake
- Other income declined 66.6% YoY to Rs.29.93 Cr, a significant headwind
- Finance costs and depreciation rose due to NACL acquisition, structural cost increase
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.